A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients

Dermatology

Volumn 205, Issue 2-3, 2002, Pages 249-254

  Sarkar, Rashmi ^a,b   Bhalla, Mala ^a   Kanwar, Amrinder J ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b PGI Campus ^*  (India)

Author keywords

Azelaic acid; Melasma; Topical steroid

Indexed keywords

AZELAIC ACID; CLOBETASOL PROPIONATE; STEROID; SUNSCREEN;

ACNE; ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; CREAM; DRUG EFFECT; DRUG RESPONSE; EVALUATION; FEMALE; HUMAN; HYPERPIGMENTATION; INTERMETHOD COMPARISON; MALE; MEDICAL ASSESSMENT; MEDICAL PHOTOGRAPHY; MONOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SKIN BURNING SENSATION; SKIN IRRITATION; SKIN PIGMENTATION; TOPICAL TREATMENT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MELANOSIS; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0036974690     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065851     Document Type: Article

References (27)

1. Newcomer VD, Lindbert MC, Stenbert TH: A melanosis of the face ('chloasma'). Arch Dermatol 1961;83:284-297.
2. Grimes PE: Melasma: Etiologic and therapeutic considerations. Arch Dermatol 1995;131:1453-1457.
3. Pathak MA, Fitzpatrick TB, Kraus EW: Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol 1986;15:894-899.
4. Bleehen SS, Ebling FJG, Champion RH: Disorders of skin colour; in Champion RH, Burton JL, Ebling FJG (eds): Textbook of Dermatology. Oxford, Blackwell Scientific Publications, 1992, vol 3, pp 1596-1597.
5. Pandya AG, Guevara IL: Disorders of hyperpigmentation. Dermatol Clin 2000;18:91-98.
6. Sanchez NP, Pathak MA, Sato S, et al: Melasma: A clinical, light microscopic, ultrastructural and immunofluorescence study. J Am Acad Dermatol 1981;4:698-710.
7. Gilchrist BA: Localization of melamin pigmentation with Wood's lamp. Br J Dermatol 1977; 96:245-248.
8. Hoshow RA, Zimmerman KG, Menter A: Ochronosis-like pigmentation from hydroquinone bleaching creams in American Blacks. Arch Dermatol 1985;121:105-108.
9. Kimbrough-Green CK, Griffiths CEM, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ: Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol 1994;130:727-733.
10. Kanwar AJ, Dhar S, Kaur S: Treatment of melasma with potent topical corticosteroids. Dermatology 1994;188:170.
11. Engasser PE, Maibach HI: Cosmetics and dermatology: Bleaching cream. J Am Acad Dermatol 1981;5:143-147.
12. Penneys NS: Ochronosis-like pigmentation from hydroquinone bleaching creams. Arch Dermatol 1985;121:1239-1240.
13. Griffiths CEM, Finkel LJ, Ditre CM, et al: Topical tretinoin (retinoic acid) improves melasma: A vehicle-controlled clinical trial. Br J Dermatol 1993;129:415-421.
14. Kenney JA Jr: Pigmentary disorders in black skin. Clin Dermatol 1987;7:1-10.
15. Neering H: Treatment of melasma (chloasma) by local application of a steroid cream. Dermatologica 1975;15:349-353.
16. Rigoni C, Toffolo P, Serrie R, Caputo R: Use of a cream based on 20% azelaic acid in the treatment of melasma (in Italian). G Ital Dermatol Venereol 1989;124:1-6.
17. Verallo-Rowell VM, Verallo V, Graupe K, Lopez-Villafuerte L, Garcia-Lopez M: Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl 1989;143:58-61.
18. Balina LM, Graupe K: The treatment of melasma 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 1991;30:893-895.
19. Nazarro-Porro M: The use of azelaic acid in hyperpigmentation. Rev Contemp Pharmacother 1993;4:415-423.
20. Nazarro-Porro M: Azelaic acid. J Am Acad Dermatol 1987;17:1033-1041.
21. Breathnach AS: Melanin hyperpigmentation of the skin: Melasma, topical treatment with azelaic acid and other therapies. Cutis 1996; 57(suppl):36-45.
22. Filton A, Goa KL: Azelaic acid: A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991;41:780-798.
23. Breathnach AS: Azelaic acid in clinical medicine: A historical overview. Rev Contemp Pharmacother 1993;4:395-401.
24. Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S: Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther 1998;20:945-959.
25. Kakita LS, Lowe NJ: Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: A clinical comparison with hydroquinone. Clin Ther 1998;20:960-970.
26. Verallo-Rowell VM, Sioson-Delos Reyes G: South Asian experience with azelaic acid in melasma. Med Prog J 1993;20(suppl):26-30.
27. Kligman AM, Willis I: A new formula for depigmenting human skin. Arch Dermatol 1975;111:40-48.